Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Hereditary pheochromocytoma and paraganglioma: screening and follow-up strategies in asymptomatic mutation carriers].

Annales d'endocrinologie - 1 Sept 2018

Vermalle Marie, Tabarin Antoine, Castinetti Frederic

Abstract excerpt

The management of pheochromocytoma and paraganglioma has deeply evolved over the last years due to the discovery of novel genes of susceptibility, especially SDHx, MAX and TMEM127. While the modalities of diagnosis and management of patients presenting with hereditary pheochromocytoma and paraganglioma are now well defined, screening and follow-up strategies for asymptomatic mutation carriers remain a matter of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Gland Neoplasms
Share to Basic Helix-Loop-Helix Leucine Zipper Transcription Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Heterozygote

Share to Membrane Proteins

Share to Paraganglioma

Share to Pheochromocytoma

Share to Succinate Dehydrogenase

Source

Identifiers

PMID: 30213301
DOI: 10.1016/S0003-4266(18)31234-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Hereditary pheochromocytoma and paraganglioma: screening and follow-up strategies in asymptomatic mutation carriers].PMID 30213301Read ↗

Overview of recent guidelines and consensus statements on initial screening and management of phaeochromocytoma and paraganglioma in SDHx pathogenic variant carriers and patientsSemantic proximity Read ↗

Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paragangliomaSemantic proximity Read ↗

Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention.Semantic proximity Read ↗

Pheochromocytoma and paraganglioma syndromes: genetics and management updateSemantic proximity Read ↗

Paragangliomas/Pheochromocytomas: Clinically Oriented Genetic TestingSemantic proximity Read ↗

Genotype-Phenotype Features of Germline Variants of the TMEM127 Pheochromocytoma Susceptibility Gene: A 10-Year Update.Semantic proximity Read ↗

Von Hippel-Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood.Semantic proximity Read ↗

Novel hereditary forms of pheochromocytomas and paragangliomas.Semantic proximity Read ↗

A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma.Semantic proximity Read ↗

Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variantsSemantic proximity Read ↗

Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statementSemantic proximity Read ↗

Recent Advances in Histopathological and Molecular Diagnosis in Pheochromocytoma and Paraganglioma: Challenges for Predicting Metastasis in Individual PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.